Realta Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,435
Closed -$214K 324
2025
Q1
$214K Sell
8,435
-6,407
-43% -$168K 0.1% 163
2024
Q4
$395K Buy
14,842
+4,293
+41% +$116K 0.16% 122
2024
Q3
$307K Sell
10,549
-17,179
-62% -$501K 0.14% 138
2024
Q2
$776K Sell
27,728
-10,761
-28% -$296K 0.15% 151
2024
Q1
$1.07M Buy
38,489
+62
+0.2% +$1.72K 0.22% 114
2023
Q4
$1.11M Sell
38,427
-2,435
-6% -$73.6K 0.25% 99
2023
Q3
$1.5M Sell
40,862
-4,170
-9% -$147K 0.34% 63
2023
Q2
$1.65M Buy
45,032
+4,422
+11% +$172K 0.36% 57
2023
Q1
$1.66M Sell
40,610
-2,885
-7% -$125K 0.4% 57
2022
Q4
$2.23M Sell
43,495
-496
-1% -$23.8K 0.54% 34
2022
Q3
$1.93M Buy
43,991
+900
+2% +$43.7K 0.5% 37
2022
Q2
$2.25M Buy
43,091
+1,406
+3% +$71.6K 0.55% 32
2022
Q1
$2.16M Sell
41,685
-2,393
-5% -$124K 0.43% 45
2021
Q4
$2.6M Sell
44,078
-1,278
-3% -$63.3K 0.57% 31
2021
Q3
$1.95M Buy
45,356
+537
+1% +$23.8K 0.46% 48
2021
Q2
$1.75M Sell
44,819
-2,648
-6% -$103K 0.42% 54
2021
Q1
$1.72M Buy
47,467
+5,260
+12% +$187K 0.45% 52
2020
Q4
$1.55M Sell
42,207
-1,035
-2% -$38K 0.44% 52
2020
Q3
$1.51M Buy
43,242
+10,272
+31% +$360K 0.5% 40
2020
Q2
$1.02M Buy
32,970
+1,772
+6% +$60.2K 0.34% 64
2020
Q1
$966K Sell
31,198
-5,425
-15% -$185K 0.41% 52
2019
Q4
$1.35M Buy
36,623
+6,783
+23% +$242K 0.37% 48
2019
Q3
$1.02M Sell
29,840
-2,441
-8% -$88.8K 0.28% 74
2019
Q2
$1.32M Buy
32,281
+8,812
+38% +$350K 0.37% 48
2019
Q1
$943K Buy
+23,469
New +$940K 0.43% 54

Other funds holding PFE

Realta Investment Advisors's PFE Position: Q2 2025 in Review

Realta Investment Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 8,435 shares — an estimated $214K sold.

Realta Investment Advisors first reported a position in PFE in Q1 2019 and held it in 25 quarters. The position peaked at $2.6M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Realta Investment Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Realta Investment Advisors sold 8,435 Pfizer shares in Q2 2025, an estimated $214K.
  • Realta Investment Advisors first reported a position in Pfizer in Q1 2019 and held it in 25 quarters.
  • Realta Investment Advisors's Pfizer position peaked at $2.6M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Realta Investment Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.